Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Reuben Harris
University of Minnesota, Department: Biochemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
ApoGen Biotechnologies
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Drs Harris and Harki (see separate FCOI report) earn consulting income and hold equity in ApoGen BioTechnologies. ApoGen owns the APOBEC3 intellectual property invented by Harris and Harki. This project uses APOBEC3 IP. More details are found in the uploaded management plan.
APOBEC3 STRUCTURAL STUDIES
HIV infection can be controlled but not cured by current antiretroviral regimens. Understanding more about essential human/viral macromolecular interactions will provide new biological insights and could provide important information for future exploitation towards novel and potentially curative antiretroviral therapies.
Filed on February 14, 2018.
Tell us what you know about Reuben Harris's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Reuben Harris filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Reuben Harris | University of Minnesota | Conflict of Interest | ApoGen Biotechnologies | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.